Belpointe Asset Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,946
| Closed | -$264K | – | 1028 |
|
|
2024
Q4 | $264K | Buy |
1,946
+36
| +2% | +$4.89K | 0.02% | 704 |
|
|
2024
Q3 | $239K | Buy |
1,910
+19
| +1% | +$2.37K | 0.01% | 740 |
|
|
2024
Q2 | $299K | Sell |
1,891
-48
| -2% | -$7.58K | 0.02% | 588 |
|
|
2024
Q1 | $251K | Buy |
+1,939
| New | +$251K | 0.02% | 666 |
|
|
2023
Q2 | – | Sell |
-1,251
| Closed | -$172K | – | 3009 |
|
|
2023
Q1 | $172K | Sell |
1,251
-40
| -3% | -$5.51K | 0.01% | 1009 |
|
|
2022
Q4 | $167K | Buy |
1,291
+122
| +10% | +$15.8K | 0.01% | 968 |
|
|
2022
Q3 | $129K | Buy |
+1,169
| New | +$129K | 0.01% | 1032 |
|
|
2021
Q4 | – | Sell |
-1,810
| Closed | -$167K | – | 1246 |
|
|
2021
Q3 | $167K | Buy |
1,810
+250
| +16% | +$23.1K | 0.01% | 934 |
|
|
2021
Q2 | $121K | Buy |
+1,560
| New | +$121K | 0.01% | 1049 |
|